J M Satagopan

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi A bayesian approach to detect quantitative trait loci using Markov chain Monte Carlo
    J M Satagopan
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10021 6094, USA
    Genetics 144:805-16. 1996
  2. ncbi A note on competing risks in survival data analysis
    J M Satagopan
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York 10021, USA
    Br J Cancer 91:1229-35. 2004
  3. ncbi The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations
    J M Satagopan
    Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Cancer Epidemiol Biomarkers Prev 10:467-73. 2001
  4. ncbi Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment
    F C Maluf
    The Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center and the Department of Medicine, Joan and Sanford Weill Medical College of Cornell University, New York, USA
    Ann Oncol 17:1677-86. 2006

Collaborators

Detail Information

Publications4

  1. ncbi A bayesian approach to detect quantitative trait loci using Markov chain Monte Carlo
    J M Satagopan
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10021 6094, USA
    Genetics 144:805-16. 1996
    ..High posterior density regions of the marginal densities are obtained as confidence regions. We examine flowering time data from double haploid progeny of Brassica napus to illustrate the proposed method...
  2. ncbi A note on competing risks in survival data analysis
    J M Satagopan
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York 10021, USA
    Br J Cancer 91:1229-35. 2004
    ..We compare the resulting estimates with those obtained using the Kaplan-Meier approach to demonstrate the importance of appropriately estimating the cumulative incidence of an event of interest in the presence of competing risk events...
  3. ncbi The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations
    J M Satagopan
    Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Cancer Epidemiol Biomarkers Prev 10:467-73. 2001
    ..The risks appear to be different for carriers of BRCA1 and BRCA2 mutations...
  4. ncbi Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment
    F C Maluf
    The Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center and the Department of Medicine, Joan and Sanford Weill Medical College of Cornell University, New York, USA
    Ann Oncol 17:1677-86. 2006
    ..Both individual and cooperative effects of these gene products may affect the biological behavior of primary bladder cancers and long-term outcome to standard therapy...